OBIO Stock Analysis: Buy, Sell, or Hold?
OBIO - Orchestra BioMed Holdings, Inc. Ordinary Shares
$3.49
-0.24 (-6.43%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When OBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called OBIO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OBIO is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: OBIO is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: OBIO is currently trading at $3.49, which is considered oversold relative to its 30-day fair value range of $3.94 to $4.55.
Technical Outlook: Technically, OBIO is in a strong uptrend. The price is currently testing key support at $3.60. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: OBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $13.43 (+260.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OBIO is in a strong uptrend. The price is currently testing key support at $3.60. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: OBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $13.43 (+260.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.94 -
$4.55
Company Quality Score
49/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
41.7%
Protect Your Profits
Holding OBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 260.0% below Wall St target ($13.43)
Fair Price Analysis
30-Day Fair Range
$3.94 -
$4.55
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.22
(35.0%)
Support & Resistance Levels
Support Level
$3.60
Resistance Level
$4.37
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.34
Wall Street Target
$13.43
(+260.0%)
Revenue Growth (YoY)
-12.8%
Last updated: January 30, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OBIO showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jason Aryeh
BUY
1000 shares
2025-09-19
Andrew Lawrence Taylor
BUY
2000 shares
2025-08-25
Darren Sherman
BUY
3000 shares
2025-08-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$273 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 55 HOLD |
Advanced OBIO Option Strategies
Professional options setups generated by AI based on today's OBIO price and gamma walls.
